Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

A review of adult obesity prevalence, trends, risk factors, and epidemiologic methods in Kuwait.

Karageorgi S, Alsmadi O, Behbehani K.

J Obes. 2013;2013:378650. doi: 10.1155/2013/378650. Epub 2013 Dec 17. Review.

2.

Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.

Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, Berchuck A, Pearce CL, Pike M, Ness RB, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Rossing MA, Schildkraut J, Risch H, Goodman MT; Ovarian Cancer Association Consortium.

Cancer Prev Res (Phila). 2013 Aug;6(8):811-21. doi: 10.1158/1940-6207.CAPR-13-0037. Epub 2013 Jun 12.

3.

Prospective analysis of vitamin D and endometrial cancer risk.

Liu JJ, Bertrand KA, Karageorgi S, Giovannucci E, Hankinson SE, Rosner B, Maxwell L, Rodriguez G, De Vivo I.

Ann Oncol. 2013 Mar;24(3):687-92. doi: 10.1093/annonc/mds509. Epub 2012 Nov 7.

4.

Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium.

Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, Lacey JV Jr, Liang X, Lissowska J, Lu L, Lurie G, Mack T, Matsuno RK, McCann S, Moysich KB, Olson SH, Rastogi R, Rebbeck TR, Risch H, Robien K, Schairer C, Shu XO, Spurdle AB, Strom BL, Thompson PJ, Ursin G, Webb PM, Weiss NS, Wentzensen N, Xiang YB, Yang HP, Yu H, Horn-Ross PL, De Vivo I; Australian National Endometrial Cancer Study Group.

Am J Epidemiol. 2012 Aug 15;176(4):269-78. Epub 2012 Jul 23.

5.

GSTM1 and GSTT1 copy number variation in population-based studies of endometrial cancer risk.

Karageorgi S, Prescott J, Wong JY, Lee IM, Buring JE, De Vivo I.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1447-52. doi: 10.1158/1055-9965.EPI-11-0190. Epub 2011 May 10.

6.

Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk.

Karageorgi S, McGrath M, Lee IM, Buring J, Kraft P, De Vivo I.

Gynecol Oncol. 2011 Apr;121(1):54-8. doi: 10.1016/j.ygyno.2010.11.014. Epub 2010 Dec 3.

7.

Perineal use of talcum powder and endometrial cancer risk.

Karageorgi S, Gates MA, Hankinson SE, De Vivo I.

Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1269-75. doi: 10.1158/1055-9965.EPI-09-1221. Epub 2010 Apr 20.

8.

Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004.

Karageorgi S, Hankinson SE, Kraft P, De Vivo I.

Int J Cancer. 2010 Jan 1;126(1):208-16. doi: 10.1002/ijc.24672.

9.

Multifunctional specificity of the protein C/activated protein C Gla domain.

Preston RJ, Ajzner E, Razzari C, Karageorgi S, Dua S, Dahlb├Ąck B, Lane DA.

J Biol Chem. 2006 Sep 29;281(39):28850-7. Epub 2006 Jul 25.

Supplemental Content

Loading ...
Support Center